Navigation Links
The Other Side of Hematopoietic Stem Cell Transplant

When everyone thought that Hematopoietic stem cell transplant could help in fighting cancer,// a recent study issued an alarming finding. According to this, if HSCT recipients are more prone to a relapse of caner in the following cases:
a. if they were older at the time of tranplant b. if the stem cells are from a female donor.

This second cancer could occur within ten years from the time of the original transplant. This is more pronounced in them than the general public. In the event of the recipient being in the older age group i.e, older than forty years, the risk quadruples.

Myeloablative, allogeneic HSCT is an effective standard therapy for specific life-threatening diseases, such as leukemia or myelodysplastic syndrome, for which blood cell lineages (which originate principally in the bone marrow and circulate in the blood) are abnormal. Destroying the patient's own unhealthy stem cells in the bone marrow and replacing them with a compatible donor's stem cells offers the chance of cure for a disease that otherwise has a high mortality rate with non-transplant therapies. While the procedure can be lifesaving, it is associated with serious short-term adverse effects, such as mucostitis, infections, and liver vascular obstruction as well as the potential long-term complication of developing of a second, usually solid cancer.

To estimate the risk and identify risk factors associated with this outcome, Genevieve Gallagher, M.D. and Donna L. Forrest, M.D. of the BC Cancer Agency and the University of British Columbia, retrospectively reviewed the medical records of 926 patients treated with myeloablative stem cell transplants over an 18-year period.

They found that at their institution the 10-year incidence of second cancers in these patients was 3.1 percent. When nonmelanoma skin cancer and carcinoma in situ of the cervix were excluded, incidence was 2.3 percent. That risk was 1.85 times that of the general pop
'"/>




Page: 1 2

Related medicine news :

1. Twins Less Prone to Suicide Than Others
2. Sleep Disorders Could Indicate Other Medical Problems
3. Features Of The Brain Affect Asthma And Other Stress Related Disorders
4. Smokers Avoid Dental Care More Than Others
5. Brain Patterns In Amusia May Be Related To Other Disorders
6. Genetic Eye Disorder Can Have Other Implications
7. Some See A Hopeless End, While Others See An Endless Hope
8. Dead Palestinian Boy Saves Lives Of Six Others
9. Avastin, anti-Cancer Drug leads to Blindness and Other Complications
10. Hamsters Shows How Our Brains May Recognize Other Individuals
11. Anticancer Properties of Vitamin D Could Be Separated From Other Functions
Post Your Comments:
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Increasing exercise, water and fruit consumption leads to success, study finds , , FRIDAY, Dec. 4 (HealthDay News) -- Increased exercise, reduced soda consumption and self-weighing are among
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Teens Lose More Weight Using Healthy Strategies 2
...enter Institute (JCVI) announced today that they h... from the National Institute of Allergy and Infect...utes of Health, as one of their Genomic Sequencing...nable JCVI to continue to expand its decades-long ...
...th Month and groups across the country and around ...n celebration of this awareness period. The purpo...ess of preventable health problems and encourage e...Father,s Day, a special awareness period recognize...
...a global leader in high-performance polymer extrus... International Sales. Gifford is experienced in ge...s development within the manufacturing, financial,... success record in terms of the sale of complex an...
...ability equates to success, , , FRIDAY, Ma...ive pitchers the extra edge they need to rule the ...lvic control of 24 pitchers, ages 18 to 26, in the...s wore a device that measured pelvic stability by ...
...s Expanding Ocular Pharmaceuticals Portfolio and O...cular Bacterial Pathogens(1) - , , , MADISON, N....ye health, today announced that the U.S. Food and ...eferred to as "pink eye." Besivance(TM) is a ne...
...vides Better Diagnosis and Treatment for Patients ...Kenneth L. Reed, M.D. performed the first revoluti...mpression (D.N.D.) procedure to treat acute and ...th area. The surgery is also currently being perfo...
Other Medicine News:Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 2Health News:J. Craig Venter Institute Awarded $43 Million, Five Year Contract From NIAID to Continue to Develop and Provide Sequencing, Genotyping, and Bioinformatics Expertise and Services in Infectious Diseases 3Health News:Join Men's Health Network in Celebration of Men's Health Month 2Health News:Join Men's Health Network in Celebration of Men's Health Month 3Health News:Gifford Named Zeus Director of International Sales 2Health News:Pitching Prowess May Start With the Pelvis 2Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 2Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 3Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 4Health News:Bausch & Lomb Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') 5Health News:Kenneth L. Reed, M.D. Performs First State of the Art AccuraScope(TM) Procedure in Dallas 2
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 62068 1Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 62068 2Agito Networks Recognized in the 2009 Tech Innovators Awards Program by Everything Channel 62068 3Bionorica Offers Expert Resources Health Tips for Natural Moms 62064 1Bionorica Offers Expert Resources Health Tips for Natural Moms 62064 2Two Major Universities Join Nations Leading Postgrad Bio Job Board 14970 1Two Major Universities Join Nations Leading Postgrad Bio Job Board 14970 2
... Pharmasset, Inc.,(Nasdaq: VRUS ) announces that... clevudine for the treatment of chronic hepatitis ...sults of R7128 for the treatment of,chronic hepati...rs in Drug,Development in Viral Hepatitis (HEP-DAR...cember 9 - 13, 2007. The abstract titles and abbre...
... Magazines like Time, Newsweek,and U.S. World and ...,probiotics. Researchers have found compelling evi...t key to digestive and immune health, but Eastern,...f probiotics, found in,fermented foods such as yog...nning to tout probiotic benefits, Russian scientis...
Other Medicine Technology:Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART 2Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART 3Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART 4Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART 5Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART 6Are Muramyl Peptides the Magic Bullet in Probiotics? 2Are Muramyl Peptides the Magic Bullet in Probiotics? 3
New Image Cut-to-Fit Flextend Skin Barrier, Floating Flange
New Image Cut-to-Fit Convex Flextend Skin Barrier, with Tape
CenterPointLock Urostomy Pouch
CenterPointLock Sterile Urostomy Kit
Medicine Products: